Research Prioritisation in Preparedness for and Response to Outbreaks of High-consequence Pathogens: a Scoping Review

Overview

Journal BMC Med

Publisher Biomed Central

Specialty General Medicine

Date 2025 Mar 10

PMID 40059172

Authors

Emilia Antonio

Nicolas Pulik

Susan Khader Ibrahim

Adebisi Adenipekun

Shanthi Levanita

Isabel Foster

Dorothy Chepkirui

Eli Harriss

Louise Sigfrid

Alice Norton

Affiliations

Soon will be listed here.

Abstract

Background: Priority setting for research on epidemic/pandemic-prone pathogens is essential for the allocation of limited resources to optimise impact. It involves the identification of gaps in knowledge crucial to effective preparedness and response to outbreaks. This review maps priority-setting exercises, reviews their approaches to research prioritisation and describes associated monitoring and evaluation processes for research priorities on high-consequence pathogens.

Methods: Using search terms associated with high-consequence pathogens, as defined by the WHO (2020), EMERGE (2019), European CDC (2022) and the Association of Southeast Asian Nations (2021), and research prioritisation, we searched WHO Global Index Medicus; Ovid Medline; Ovid Embase; Ovid Global Health; and Scopus. Grey literature sources were Google Scholar and the WHO websites, complemented by recommendations from stakeholder consultation. Two independent reviewers screened abstracts and full-texts including documents describing research prioritisation activities. Results were analysed using descriptive statistics and narrative synthesis.

Results: We identified 125 publications presenting priority setting activities on 17 high-consequence pathogens published between 1975 and 2022. Most (62%) were related to SARS-CoV-2, 5.6% to Ebola virus and 5% to Zika virus. Three different broad approaches to setting priorities were identified, most (53%) involved external consultations with experts. Few (6%) indicated plans to monitor progress against set priorities.

Conclusions: Our results highlight the diversity in research prioritisation practice in the context of high-consequence pathogens and a limited application of the existing standards in health research prioritisation. An increased uptake of these standards and harmonisation of practice may improve quality and confidence and ultimately improve alignment of funded research with the resulting priorities.

References

Uyeki T, Erlandson K, Korch G, OHara M, Wathen M, Hu-Primmer J . Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus. Emerg Infect Dis. 2016; 22(7). PMC: 4918159. DOI: 10.3201/eid2207.160022. View

Payne D, Franzke L, Stehr-Green P, Schwartz B, McNeil M . Development of the Vaccine Analytic Unit's research agenda for investigating potential adverse events associated with anthrax vaccine adsorbed. Pharmacoepidemiol Drug Saf. 2006; 16(1):46-54. DOI: 10.1002/pds.1213. View

Doherty T, Rohde S, Besada D, Kerber K, Manda S, Loveday M . Reduction in child mortality in Ethiopia: analysis of data from demographic and health surveys. J Glob Health. 2018; 6(2):020401. PMC: 4854592. DOI: 10.7189/jogh.06.020401. View

Corbel V, Fonseca D, Weetman D, Pinto J, Achee N, Chandre F . International workshop on insecticide resistance in vectors of arboviruses, December 2016, Rio de Janeiro, Brazil. Parasit Vectors. 2017; 10(1):278. PMC: 5457540. DOI: 10.1186/s13071-017-2224-3. View

Yoshida S, Rudan I, Cousens S . Setting health research priorities using the CHNRI method: VI. Quantitative properties of human collective opinion. J Glob Health. 2016; 6(1):010503. PMC: 4920008. DOI: 10.7189/jogh.06.010503. View

Faghy M, Arena R, Babu A, Christle J, Marzolini S, Popovic D . Post pandemic research priorities: A consensus statement from the HL-PIVOT. Prog Cardiovasc Dis. 2022; 73:2-16. PMC: 9278010. DOI: 10.1016/j.pcad.2022.07.001. View

Eder M, Cortes F, de Siqueira Filha N, Araujo de Franca G, Degroote S, Braga C . Scoping review on vector-borne diseases in urban areas: transmission dynamics, vectorial capacity and co-infection. Infect Dis Poverty. 2018; 7(1):90. PMC: 6120094. DOI: 10.1186/s40249-018-0475-7. View

Bucher A, Antonio E, Jabin N, Grund H, Jones C, Advani N . A living mapping review for COVID-19 funded research projects: final (27 month) update. Wellcome Open Res. 2023; 5:209. PMC: 7579366. DOI: 10.12688/wellcomeopenres.16259.10. View

Norton A, Sigfrid L, Antonio E, Bucher A, Ndwandwe D . Improving coherence of global research funding: Pandemic PACT. Lancet. 2024; 403(10433):1233. DOI: 10.1016/S0140-6736(24)00452-5. View

Bausch D, Sprecher A, Jeffs B, Boumandouki P . Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. Antiviral Res. 2008; 78(1):150-61. DOI: 10.1016/j.antiviral.2008.01.152. View

Cowling B, Yu H . Ebola: worldwide dissemination risk and response priorities. Lancet. 2014; 385(9962):7-9. DOI: 10.1016/S0140-6736(14)61895-X. View

10.

Wiwanitkit V, Tambo E, Ugwu E, Ngogang J, Zhou X . Are surveillance response systems enough to effectively combat and contain the Ebola outbreak?. Infect Dis Poverty. 2015; 4(1):7. PMC: 4322436. DOI: 10.1186/2049-9957-4-7. View

11.

Sutton J, Rivera Y, Sell T, Moran M, Bennett Gayle D, Schoch-Spana M . Longitudinal Risk Communication: A Research Agenda for Communicating in a Pandemic. Health Secur. 2020; 19(4):370-378. DOI: 10.1089/hs.2020.0161. View

12.

Weerakkody S, Arina P, Glenister J, Cottrell S, Boscaini-Gilroy G, Singer M . Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research. Lancet Respir Med. 2021; 10(2):199-213. PMC: 8577844. DOI: 10.1016/S2213-2600(21)00414-8. View

13.

Valles X, Stenseth N, Demeure C, Horby P, Mead P, Cabanillas O . Human plague: An old scourge that needs new answers. PLoS Negl Trop Dis. 2020; 14(8):e0008251. PMC: 7451524. DOI: 10.1371/journal.pntd.0008251. View

14.

Mody L, Akinboyo I, Babcock H, Bischoff W, Cheng V, Chiotos K . Coronavirus disease 2019 (COVID-19) research agenda for healthcare epidemiology. Infect Control Hosp Epidemiol. 2021; 43(2):156-166. PMC: 8160487. DOI: 10.1017/ice.2021.25. View

15.

Liu K, Howard R, Banerjee S, Comas-Herrera A, Goddard J, Knapp M . Dementia wellbeing and COVID-19: Review and expert consensus on current research and knowledge gaps. Int J Geriatr Psychiatry. 2021; 36(11):1597-1639. PMC: 8237017. DOI: 10.1002/gps.5567. View

16.

Bueno de Mesquita P, Delp W, Chan W, Bahnfleth W, Singer B . Control of airborne infectious disease in buildings: Evidence and research priorities. Indoor Air. 2021; 32(1):e12965. DOI: 10.1111/ina.12965. View

17.

Simpson G, Quesada F, Chatterjee P, Kakkar M, Chersich M, Thys S . Research priorities for control of zoonoses in South Africa. Trans R Soc Trop Med Hyg. 2021; 115(5):538-550. PMC: 8083559. DOI: 10.1093/trstmh/trab039. View

18.

Shook L, Fallah P, Silberman J, Edlow A . COVID-19 Vaccination in Pregnancy and Lactation: Current Research and Gaps in Understanding. Front Cell Infect Microbiol. 2021; 11:735394. PMC: 8481914. DOI: 10.3389/fcimb.2021.735394. View